RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results and Operational Highlights

Provided By PR Newswire

Last update: Apr 28, 2023

Having extinguished all debt and significantly reduced cost-base, RedHill is now focused on late-stage pipeline advancement, in collaboration with U.S. and other governments, commercial growth and revenue-generating product acquisition opportunities